| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology Unit (L.I., A.F.) and Hormonal Laboratory (C.V.), Hospital Sant Joan de Déu, University of Barcelona, 08950 Esplugues, Barcelona, Spain; Department of Pediatrics (K.O., D.D.), University of Cambridge, Cambridge CB2 2QQ, United Kingdom; and Department of Pediatrics (F.d.Z.), University of Leuven, 3000 Leuven, Belgium
Address all correspondence and requests for reprints to: Lourdes Ibáñez, M.D., Ph.D., Endocrinology Unit, Hospital Sant Joan de Déu, University of Barcelona, Passeig de Sant Joan de Déu, 2, 08950 Esplugues, Barcelona, Spain. E-mail: libanez{at}hsjdbcn.org.
A minority of children born small for gestational age (SGA) maintain a slow weight gain and a short stature (SS). At the other end of the spectrum are SGA children who show rapid postnatal weight gain and catch-up growth; these subjects may develop hyperinsulinemia, exaggerated adrenarche with precocious pubarche (PP), and an associated proinflammatory state with raised IL-6 and reduced adiponectin levels.
Metformin therapy in SGA-PP girls attenuates the hyperinsulinemia, the adrenal androgen excess, and the proinflammatory state. In contrast, GH therapy in SGA-SS children promotes height gain but may induce hyperinsulinemia. Both groups are associated with increased risk markers for future cardiovascular disease. Therefore, we studied markers of inflammation in both SGA subpopulations at baseline and after their respectively corrective therapies.
SGA-PP girls (n = 33; mean age, 8 yr; body mass index, 18.5 kg/m2) were randomized to remain untreated or to receive metformin (425 mg/d) for 6 months. SGA-SS children (n = 29; mean age, 7 yr; body mass index, 14.7 kg/m2) were randomly assigned to remain untreated or to receive GH (60 µg/kg/d). In SGA-PP girls, the mean neutrophil count (4.0 x 1000/mm3) was more than 2 SD above the mean reference level (2.8 x 1000/mm3, P < 0.001); this remained stable over 6 months in untreated girls but dropped in metformin-treated girls by –1.1 x 1000/mm3 (P = 0.002).
In SGA-SS children, neutrophil counts were also higher at baseline (3.3 x 1000/mm3, P < 0.01). This remained stable in untreated children but rose in GH-treated children by +1.1 x 1000/mm3 (P = 0.004). GH-treated children also showed a rise in circulating IL-6 and dehydroepiandrosterone-sulfate levels and a fall in adiponectin levels.
In conclusion, neutrophil counts were elevated in SGA children. In SGA girls with PP, the present results corroborate the antiinflammatory benefits of metformin therapy. In contrast, high-dose GH therapy in short SGA children may increase neutrophil counts and lead to a less favorable adipocytokine profile. Future studies with combined GH plus metformin treatment in short SGA children may clarify whether insulin resistance is a mechanism linking GH therapy to markers of inflammation.
This article has been cited by other articles:
 |
|
 |
|
  C. J. Kojima, H. G. Kattesh, M. P. Roberts, and T. Sun Physiological and immunological responses to weaning and transport in the young pig: Modulation by administration of porcine somatotropin J Anim Sci, November 1, 2008; 86(11): 2913 - 2919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Argente, R. Gracia, L. Ibanez, A. Oliver, E. Borrajo, A. Vela, J. P. Lopez-Siguero, M. L. Moreno, F. Rodriguez-Hierro, and on behalf of the Spanish SGA Working Group Improvement in Growth after Two Years of Growth Hormone Therapy in Very Young Children Born Small for Gestational Age and without Spontaneous Catch-Up Growth: Results of a Multicenter, Controlled, Randomized, Open Clinical Trial J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3095 - 3101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Orio, F. Manguso, S. Di Biase, A. Falbo, F. Giallauria, D. Labella, A. Tolino, G. Lombardi, A. Colao, and S. Palomba Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study Eur. J. Endocrinol., July 1, 2007; 157(1): 69 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Willemsen, M. van Dijk, Y. B. de Rijke, A. W. van Toorenenbergen, P. G. Mulder, and A. C. Hokken-Koelega Effect of Growth Hormone Therapy on Serum Adiponectin and Resistin Levels in Short, Small-for-Gestational-Age Children and Associations with Cardiovascular Risk Parameters J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 117 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ibanez, K. Ong, C. Valls, M. V. Marcos, D. B. Dunger, and F. de Zegher Metformin Treatment to Prevent Early Puberty in Girls with Precocious Pubarche J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2888 - 2891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ibanez, K. Ong, D. B. Dunger, and F. de Zegher Early Development of Adiposity and Insulin Resistance after Catch-Up Weight Gain in Small-for-Gestational-Age Children J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2153 - 2158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Srinivasan, G. R. Ambler, L. A. Baur, S. P. Garnett, M. Tepsa, F. Yap, G. M. Ward, and C. T. Cowell Randomized, Controlled Trial of Metformin for Obesity and Insulin Resistance in Children and Adolescents: Improvement in Body Composition and Fasting Insulin J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2074 - 2080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ibanez, K. Ong, D. B. Dunger, and F. d. Zegher Effects of Growth Hormone Treatment on Neutrophil Count in Children Born Small for Gestational Age Pediatrics, May 1, 2006; 117(5): 1868 - 1869. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
